Table 4 Comparison of clinical characteristics between BALF bacteriologically negative and positive patients within sputum negative pulmonary TB patients and those without sputum
Total | BALF (+) | BALF (−) | P-value | OR (95% CI) | |
|---|---|---|---|---|---|
N = 1028 | n = 285 | n = 743 | |||
Age | 37.4 ± 14.2 | 32.7 ± 12.8 | 39.3 ± 14.2 | < 0.001 | |
Male | 589 | 154 (26.1%) | 435 (73.9%) | 0.191 | 0.832 (0.632~ 1.096) |
TB history | 126 | 40 (31.7%) | 86 (68.3%) | 0.282 | 1.247 (0.834–1.866) |
Fever | 363 | 94 (25.9%) | 269(74.1%) | 0.333 | 0.867 (0.650–1.157) |
Night sweat | 97 | 28 (28.9%) | 69 (71.1%) | 0.792 | 1.064 (0.670–1.689) |
Cough | 751 | 213 (28.4%) | 538 (71.6%) | 0.451 | 1.127 (0.825–1.540) |
Hemoptysis | 158 | 60 (38.0%) | 98 (62.0%) | 0.002 | 1.755 (1.230–2.504) |
Lose weight | 222 | 72 (32.4%) | 150 (67.6%) | 0.077 | 1.336 (0.969–1.843) |
Bilateral lung | 268 | 92 (34.3%) | 176 (65.7%) | 0.005 | 1.536 (1.137–2.074) |
Cavity | 104 | 57 (54.8%) | 47 (45.2%) | < 0.001 | 4.108 (2.376–7.102) |
aCD4 | 595.8 ± 274.4 | 547.77 ± 246.14 | 615.8 ± 283.2 | 0.004 | |
aCD4≤500 | 264 | 92 (34.8%) | 172 (65.2%) | 0.011 | 1.540 (1.101–2.153) |
aCD8 | 420.0 ± 205.4 | 380.30 ± 181.83 | 436.7 ± 212.6 | 0.001 | |
aCD8≤500 | 468 | 153 (32.7%) | 315 (67.3%) | 0.002 | 1.992 (1.289–3.076) |
ESR | 40.9 ± 31.3 | 46.08 ± 29.97 | 39.0 ± 31.6 | 0.001 | |
IGRA (+)b | 507 | 201 (39.6%) | 306 (60.4%) | < 0.001 | 3.743 (2.478–5.655) |